22 October 2018

Consilium Strategic Communications congratulates clients shortlisted at the 14th Annual Scrip Awards 2018  


LONDON, UK; 22 October 2018 - Consilium Strategic Communications, a global leader in strategic healthcare communications, congratulates its clients that have been shortlisted for an award at the 14th Annual Scrip Awards taking place on 28 November 2018 in London. 

“The annual Scrip Awards provide the healthcare industry with an opportunity to acknowledge the highest achievers across the pharma and biotech industries and we are very proud to have a good variety of our clients shortlisted for these prestigious awards. We would like to wish all finalists, and particularly our clients, the best of luck and look forward to celebrating their achievements over the past year with them on the night.”

Mary-Jane Elliott

Managing Partner, Consilium Strategic Communications

Consilium’s clients have been shortlisted in the following categories:


Ablynx (now part of Sanofi)

  • Financing Deal of the Year (public) – Ablynx’s $200m US IPO on NASDAQ
  • IQVIA’s Clinical Advance of the Year Award – Ablynx’s Phase III HERCULES study of caplacizumab for acquired thrombotic thrombocytopenic purpura
  • Executive of the Year (for Large & Medium Cap Companies) – Edwin Moses, CEO



  • Best Technological Development in Clinical Trials – Ergomed/PrimeVigilance/Automation Anywhere’s robotic process automation software


Horizon Discovery

  • Financing Deal of the Year (public) – Horizon Discovery Group’s £80m public placing



  • Financing Deal of the Year (public) – Polyphor’s CHF165m IPO



  • Executive of the Year (for Small Cap & Private Pharma Companies) – Eduardo Bravo, CEO
  • Syneos Health's Best New Drug Award – TiGenix’s Alofisel (darvadstrocel) 


– Ends –


For more information please contact:


Consilium Strategic Communications

Mary-Jane Elliott / Chris Gardner

Tel: +44(0)20 3709 5700



Follow us: @consiliumhc



About Consilium Strategic Communications

Consilium Strategic Communications is a global leader in strategic healthcare communications and investor relations advisory with offices in Europe and across the US. Consilium's highly-skilled team provides strategic, long-term PR and IR advice to healthcare companies, Boards, senior decision makers and executives on critical communications programmes and stakeholder challenges. The Company has established deep knowledge and expertise across all areas of the global healthcare sector through broad involvement in representing international clients spanning the Fortune 500, FTSE 100, FTSEurofirst 300 and FTSE 250, through to discrete specialist reputation management projects.


Back to previous page